Trial Registration Clinicaltrials.gov: NCT02607865 (PIONEER 3), NCT02863419 (PIONEER 4), NCT02827708 (PIONEER 5), NCT02849080 (PIONEER 7) and NCT03021187 (PIONEER 8)
Funding This research did not receive any specific funding
This means: Starting doses are conservative and intentional Adjustments are made based on individual progress The focus remains on long-term metabolic health, not rapid weight loss alone This approach reduces the risk of burnout, both physically and mentally, and helps patients stay consistent
The hypothesis regarding the impact of GLP-1 RAs on depression suggests a complex interaction within the dopaminergic system
Clinical trials of bupropion monotherapy show average weight losses of 5 to 10 pounds over 6 to 12 months
Trustpilot ratings have run in the mid-3 to 4-star range across thousands of reviews in 2024-2025